Position in PHVS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$103,206,007
+$1,826,655 QoQ
Shares Held
3,653,310
0.0% QoQ
Ownership
5.23%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VIKING GLOBAL INVESTORS LP holds $2,367,311,049 across 15 Biotechnology names. PHVS ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
11,842,434 | $879,419,148 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
7,062,077 | $398,936,729 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
6,652,448 | $184,272,809 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
4,203,567 | $134,556,179 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
2,666,690 | $130,801,144 | |
| 6 | SION |
Sionna Therapeutics, Inc.
|
3,195,181 | $128,094,806 | |
| 7 | MANE |
Veradermics, Inc
|
1,690,555 | $106,758,548 | |
| 8 | PHVS |
Pharvaris N.V.
This page
|
3,653,310 | $103,206,007 |
All Filings in PHVS
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $103,206,007 | 3,653,310 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $101,379,352 | 3,653,310 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $91,150,084 | 3,653,310 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $64,298,256 | 3,653,310 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,356,967 | 3,653,310 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $70,033,952 | 3,653,310 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $67,659,301 | 3,653,310 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,682,228 | 3,653,310 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $84,427,994 | 3,653,310 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $102,576,690 | 3,656,923 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $67,450,233 | 3,231,923 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $48,931,314 | 3,231,923 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,033,139 | 3,231,923 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $36,359,133 | 3,231,923 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $19,151,399 | 2,496,923 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $55,071,498 | 2,491,923 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $44,980,585 | 2,480,319 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $35,335,163 | 2,455,536 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $42,401,596 | 2,391,517 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $44,553,961 | 2,391,517 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $67,715,936 | 2,420,155 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||